A UK Real-world Evaluation of Efficacy and Toxicity of Second-line Trastuzumab Emtansine and Third-line Trastuzumab Deruxtecan in HER2-positive Advanced Breast Cancer.
Saved in:
| Title: | A UK Real-world Evaluation of Efficacy and Toxicity of Second-line Trastuzumab Emtansine and Third-line Trastuzumab Deruxtecan in HER2-positive Advanced Breast Cancer. |
|---|---|
| Authors: | Peters, S.1 (AUTHOR), Tang, H.C.1 (AUTHOR), Shafiq, T.1 (AUTHOR), Karim, S.1 (AUTHOR), Khan, S.1 (AUTHOR), Trivedi, S.1 (AUTHOR), Anand, A.1 (AUTHOR), Sheikh, H.B.1 (AUTHOR), Saghir, S.1 (AUTHOR), Lui, J.1 (AUTHOR), Prabhu, D.S.1 (AUTHOR), Mathew, T.1 (AUTHOR), Rakha, E.A.2 (AUTHOR), Madhusudan, S.1,2 (AUTHOR) |
| Source: | Clinical Oncology. Jun2023, Vol. 35 Issue 6, pe419-e419. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09366555 |
|---|---|
| DOI: | 10.1016/j.clon.2023.02.038 |
